Egr2 is also binds to and transcriptionally regulates VGF81,82, a potential CSF biomarker for AD progression83 and a recently discovered causal network mediator of Alzheimer’s disease whose overexpression decreases cortical tau69. Here, EGR2 is linked to early-onset autosomal dominant Alzheimer disease.